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Introduction 18
Hyperthermia and cavitation are the ultrasound-related mechanisms that have been reported to 19 cause increased intracellular drug uptake (Böhmer et al. 2009; Liu et al. 2001 ; Wu and Nyborg 20 2008; ). The term 'cavitation' describes two different physical processes, 21 stable and inertial, with the latter sometimes termed 'transient' cavitation, that affect cells in 22 different ways. Whilst evidence exists that both types of cavitation can be utilised in ultrasound-23 mediated targeted drug delivery (UmTDD) (Sundaram et Stable and inertial cavitation have been shown to have different acoustic signatures, based on their 28 differing underlying physics and the mechanical index (MI) of the ultrasound from which they 29 originate (Leighton 1997; Brennen 1995) . During stable cavitation, the bubbles oscillate, changing 30 size and sometimes shape. These oscillations are associated with the phenomenon of 31 microstreaming (Wu and Nyborg 2008) and can be detected by characteristic scattering of the 32 applied ultrasound. In the frequency domain, the detected ultrasound depends on the type of 33 oscillation (de Jong et al. 2009 ) and consists of harmonics, subharmonics and ultra-harmonics of the 34 fundamental driving ultrasound frequency. The scattered acoustic signal acquired during 35 sonoporation occurring as a result of inertial cavitation (Frenkel 2008 ) also has a characteristic 36 signature in the frequency domain, in this case broadband. Passive detection of scattered acoustic 37 emissions acquired during therapeutic ultrasound has been used to predict efficacy thresholds for 38 ablation (Jensen et al. 2013) , and explored as a means to investigate exploitable conditions for 39 sonoporation (Fan et al. 2014; Somaglino et al. 2011; Chen et al. 2003; Hallow et al. 2006 ) e.g. by 40
using the sub-harmonic spectrum amplitude as an indication of sonoporation occurrence (Hensel et 41 al. 2009 ). Thus further insight into the mechanisms responsible for biological effects related to 42 UmTDD can be gained through defining and correlating the types of cavitation generated with 43 4 transfection and cell viability results (Bazan-Peregrino et al 2012; Gao et al, 2008; Fan 2031; 44 Hassan 2010). 45
An additional major concern regarding UmTDD in vitro is the ability to differentiate cavitation 46 effects from those correlated with increased temperature and verification that any heating produced 47 unavoidably does not contribute to the observed biological effects. In this context, in the work 48 presented here the experimental environment was based on a clinical magnetic resonance imaging 49 guided focused ultrasound surgery (MRgFUS) system which allowed differentiation between the 50 heating and cavitation mechanisms associated with ultrasound application. This system was 51 characterized to gain understanding of the physical properties affecting the outcomes of cell culture 52 experiments, and hence aid in overcoming difficulties in reproducibility of results in in vitro 53
UmTDD experiments as has been raised previously by different authors ( 
Materials and Methods 65
Experimental Apparatus and Setup 66 An ExAblate 2000 system (InSightec, Tirat Carmel, Israel) was used as the sonication platform in 67 the described in vitro study. The source of ultrasound in this system is a concave phased array with 68 26 annuli each divided into eight sectors to give a total of 208 transmitting ultrasonic array elements 69 5 organised in 26 transducer rings (Tr), The radius of curvature is 160 mm, aperture 120 mm, and the 70 operating frequencies can be set in the range of 0.95 -1.35 MHz. Quasi-continuous excitation is 71 used, making the bandwidth extremely small for any given frequency. The array elements can be 72 turned on and off individually and also allow phase adjustment with 45° quantisation. An additional 73 complete concave element with radius 11.5 mm acts as a receiver, located coaxially with the 74 transmitting array to allow spectral responses to be recorded. Signals are acquired from the 75 receiving element for 150 ms every 200 ms, using a low-pass filter with a cut-off frequency of 76 approximately 700 kHz to reduce the amplitude of the transmitted signal. After each acquisition, the 77 signal is subjected to a fast Fourier transform (FFT) and the frequency domain result is recorded. 78 The ExAblate 2000 system complies with international HITU standards -IEC62555 (HITU 79 radiation force) and IEC62556 (HITU field characterization) as well as IEC60601 ("Medical 80 electrical equipment: Particular requirements for the basic safety and essential performance of high 81 intensity therapeutic ultrasound (HITU) equipment"), and is calibrated accordingly. In addition, it 82 was tested prior to each set of sonications, using the same method as for its clinical application, i.e. 83 by sonication of a specially manufactured daily quality assurance (DQA) phantom which verified 84 the dimensions of the focal zone as well as its delivery to a specified location. 85
Ninety six-well polystyrene µ-clear plates with a 0.2 mm thick base (Greiner Bio-One, Stonehouse, 86 UK) were found to be the best cell culture environment, with manageable heat effects and space to 87 fit the focal spot within the 7 mm diameter and 10 mm depth of each well. Titer-Tops sealing film 88 (EMS, Hatfield, PA, USA) with a thickness of 0.1 mm was used to seal the open tops of the wells to 89 maintain the sterility of the cells' microenvironment and to reduce acoustic boundary interface 90 effects by allowing complete plate immersion in water. 91
To ensure that the wells did not behave as ultrasonic waveguides during sonication (Sommer et al. 92 1997 , Redwood 1960 , which would shift focal point toward the distal end of the well, we reduced 93 the focal zone diameter which excited different propagation modes, allowing ultrasound 94 propagation in the well not as a plane wave but with some interference between the modes ( Figure  95 6 1A). This indicated there is a trade-off between the spot size and waveguide effects when sonicating 96 an inverted 96-well plate using focused ultrasound. 97
In order to validate the optimal parameters for sonication inside a well, acoustic field measurements 98 were performed as described below. The full experimental setup is depicted in Figure 1B and Figure  99 1C shows the order in which the wells were sonicated. To reduce secondary effects caused by 100 accumulated dissipation of acoustic power in neighbouring wells, the sonicated wells were 101 separated by wells with various contents (e.g. with microbubbles (MBs), without MBs and empty). 102
The sonication order was also set in such a way as to avoid sonicating two neighbouring wells one 103 after another and to minimize time-related effects on MBs by sonicating wells containing MBs first, 104 as shown in Figure 1C . The 96-well plate was placed 92 mm above the transducer. 105
Acoustic and Thermal Evaluation 106
To estimate acoustic power loss and unwanted heat distribution, a separate base portion of a 96-well 107 plate, supplied by the manufacturer, and the Titer-Tops sealing film were mounted in a special 108 frame and scanned acoustically. To determine how much of the acoustic power was dissipated 109 during the sonication, we utilised externally gated, pulsed sonications, each only a few seconds 110 long, using the ExAblate transducer as the ultrasound source. A 0.5 mm polyvinylidene difluoride 111 (PVDF) needle hydrophone (Precision Acoustics, Dorchester, UK) was placed in the focal plane of 112 the transducer to record the waves. Acoustic scanning equipment described previously (Gourevich 113 et al. 2013 ) was used to scan a 2D plane and the amplitude of the ultrasonic wave-front through a 114 focal plane was recorded in water and with the base and sealing parts of the 96-well plate immersed 115 between the transducer and the hydrophone. 116
The relatively small well diameter of 96-well plates means that care must be taken when they are 117 used in ultrasound-related in vitro experiments. To determine suitability, detect possible limitations, 118 and identify an appropriate sonication pattern, i.e. the focal distance (FD) and the form of the beam, 119 two sets of experiments were done. First, successively increasing proportions (20%, 50% then 120 100%) of the array elements from the centre outwards were activated coherently to narrow the focal 121 7 width increasingly, while leaving the remaining elements inactive. Second, increasing proportions 122 (0%, 50% then 100%) of the array elements were excited with random phases to determine the 123 effect of coherence. As detailed in the Results, the most appropriate activation of those investigated 124 was determined to be of the central 50% of the array elements (13 annuli) with coherent excitation. 125
An additional issue that may influence the focal behaviour is the FD inside a well. Because of the 126 plate geometry, as stated above, various disruptions can occur during the passage of the beam 127 through the well. To establish the optimal height for sonication inside a single well within a plate, 128 which will yield minimal distribution of power to the neighbouring wells, and to evaluate the 129 influence of a sonication on neighbouring wells, acoustic field measurements were performed over 130 an inverted plate at different focal points. The hydrophone in these measurements was less than 1 131 mm from the surface of the inverted plate, bringing it into close proximity with the theoretical cell 132
location. 133
To differentiate between the thermal and mechanical effects that are associated with application of 134 ultrasound, thermal measurements were made with an infrared (IR) thermal imaging camera (FLIR 135 Systems CeDIP JADE camera, Kent, UK). A 96-well plate was only partly immersed in water, to 136 overcome the opacity of water to IR wavelengths. The plate was sonicated at room temperature 137 (RT) using different acoustic power levels for 90 s each, allowing cooling time between the 138 sonications. 139
Cavitation Spectrum Measurements 140
The definition of cavitation dose, CD, used here is based on an approach in which, for each time 141 acquisition, the magnitude of the signal in the frequency domain is integrated around the 142 subharmonic frequency, f = 0.475 ±0.1 MHz, and these values are further integrated for the whole 143 The uptake of Dox into the MCF-7 cell line was investigated using fluorescence intensity 179 measurement (Infinite M200, Tecan Group, Mannedorf, Germany) with excitation and emission 180 wavelengths of 485 nm and 592 nm, respectively. Following ultrasound treatment, it was observed 181 that some cells detached from the mono-layer. This detachment was attributed to ultrasound 182 application and extensive cell washing to remove excess Dox left between the cells. As the detached 183 cells were discarded during the washes, they did not contribute to the total fluorescence reading. 184
Therefore we correlated the uptake, as indicated by the fluorescence measurements, with the 185 number of viable cells. This was achieved by normalization of the fluorescence readings by the total 186 protein amount present within each well after ultrasound exposure, using the bicinchoninic acid 187 (BCA) assay (Smith et al. 1985) . The recorded protein amounts following sonication were also 188 compared to the control groups to estimate the level of cell loss due to the different treatments. The solutions described above were added to each well, to a total volume of 420 µL, according to 201 the defined treatment groups ( Figure 1C ) and the plates were sealed using Titer-Tops (EMS, 202 Hatfield, PA, USA). The cells were sonicated continuously for 10 s with the following parameters; 203 acoustic power level, P = 1 W, as the defined output of the ExAblate 2000 system which was 204 focused at the centre of each well in all axes (FD = 97 mm); peak negative pressure, PNP = 205 0.53 MPa; intensity, I = 18.77 W/cm 2 ; mechanical index, MI = 0.54; and frequency, f = 0.95 MHz. 206
The plate was placed inverted to ensure that the MBs were in proximity to the cell monolayer, 207
owing to MB buoyancy. The sonications were performed in the order shown in Figure 1C , such that 208 the wells containing the MBs were sonicated first. 209
Following the sonication process, the cells were washed twice with phosphate-buffered saline (PBS; 210
Oxoid, Basingstoke, UK). For the uptake studies, the cells were lysed with 0.5% sodium dodecyl 211 sulphate (SDS; Sigma-Aldrich, Dorset, UK) and the total fluorescence intensity of each well was 212 recorded and normalized by total protein count using the BCA method (Smith et al. 1985) . The 213 cellular uptake of the sonicated samples was calculated as a percentage of the unsonicated samples, 214
i.e. the control group, which was seeded in the same 96-well plate: 215
The cell loss in each well after sonication was established according to the BCA absorbance 217 readings relative to the control group, by: 218
(3) 219
The viability studies were performed to determine if the sonication on its own, with and without 220 MBs, caused cell necrosis, regardless of the presence of Dox. For assessment of cell viability, the 221 same procedure was performed as in the uptake studies, where the indicated solutions were added to 222 11 the different groups and the cells were sonicated at the specified parameters. Following the 223 sonication process, 100 µL of fresh CM was added after two washes with PBS, then the cell 224 viability was either assessed immediately or cell recovery studies were performed. The latter 225 included additional 24 h incubation at 37 ºC in 5% CO 2 . The cell viability was assessed by addition 226 of 20 µL of MTT and 3 h incubation at 37 ºC in 5% CO 2 . The created formazan was dissolved in (4) 232
In the membrane permeability studies, the plate was centrifuged at 2000 rpm for 10 min to spin 233 down any cells present in the medium following sonication. 50 µL of the medium in each well were 234 transferred into a new black 96-well plate (Greiner Bio-One, Stonehouse, UK) and an equivalent 235 amount of resazurin reagent was added. After an incubation period of 10 min at RT, the stop 236 solution was added and the fluorescent signal was measured with an excitation wavelength of 237 560 nm and emission wavelength of 590 nm. The fluorescence readings were normalized by the 238 total protein amount using the BCA method as described above. The membrane permeability was 239 calculated as follows: 240
All the ultrasound cell culture studies were performed in a water environment at 30ºC, the upper 242 temperature limit of the experimental setup. 243
For each plate, nine replicates were done for each treatment group and an additional six replicates 244 for each type of control group. Throughout the various uptake, viability and membrane permeability 245 experiments, each set of applied ultrasound parameters was replicated at least three times to ensure 12 statistically significant data collection and correlation with spectral recording. All the values in the 247 results section are presented with their standard deviations. 248
Results 249

Characterisation of Setup 250
In our experimental set up we found that the base of the µ-clear 96-well plate and the Titer-Tops 251 sealing caused minimal attenuation of the acoustic signals, with, on average, 95.7% and 99.8% of 252 the transmitted power passed through the base and the sealing, respectively ( Figure 3A) . Figure 3B  253 represents the acoustic measurements at different focal points performed at 50% Tr with an acoustic 254 power of 1 W at 0.95 MHz. The acoustic field measurements above the 96-well plate, showed that I 255 in neighbouring wells is less than 4% of the peak intensity of the targeted well, with the minimal I 256 distribution to the neighbouring wells being when the focus is in the middle of the well, i.e. 257 FD = 97 mm. The acoustic field measurements showed that changing the aperture of the transducer 258 by deactivating outer elements increased the focal length and diameter as expected, as well as 259 distorting the focal shape, especially at 20% Tr ( Figure 3C ). Based on these measurements, the 260 aperture of the transducer to be applied was established as using half the transmitting elements 261 (50% Tr) and chosen such that the focal zone diameter entering the well was 2.6 mm. 262
According to the results of the thermal camera measurements presented in Figure 4 for the chosen 263 ultrasound parameters, with P = 1 W for 10 s, the overall temperature rise was only 0.44°C 264 (±0.2°C). 265
Biological Studies and Cavitation Spectrum Measurement 266
Analysis of the relationship between the cell results and the cavitation spectrum measurements was 267 applied to two groups. The first group, represented by Figure 5 , contains all the measurement points 268 from all the intracellular drug uptake and membrane permeability experiments. The second group, 269
represented by Table 1 and Figures 6 and 7 , contains results averaged ±SD in accordance with the 270 sonication order, i.e. time of sonication, presented in Figure 2B . 271 13 Figure 5A shows the dependence of intracellular drug uptake on the CD. There is a distinct 272 separation in outcome depending on the presence or absence of MBs. Without MBs, no significant 273 cavitation occurs, as is also evident in the uptake levels which are below a factor of 1.5 relative to 274 the control group. On the contrary, with MBs, the drug uptake varies by factors from 1.5 up to 3.2 275 with varying CD. Figure 5B depicts the correlation between the permeability of the cells' 276 membranes as a result of ultrasound application. 277
As can be seen in Figure 5B , there is a significant increase in the membrane permeability of the 278 cells, by a factor up to 3.5, in the presence of MBs, with an increasing trend with decreasing CD 279 values. Figure 5C shows the dependence of drug uptake on the cell loss, where a linear fitting 280 represents the relation between the uptake values and the number of cells missing from each well 281 after sonication and washing. According to this trend, higher levels of cell loss correspond to higher 282 uptake values, which can be explained by the fact that larger effects on the cell membrane cause 283 greater penetration of the cytotoxic drug into the cells. This is also evident from the linear 284 correlation between the uptake and the cell membrane permeability ( Figure 5D ). 285 Table 1 differentiates between stable and inertial cavitation for the different wells containing MB, 286 according to the order of sonication. The classification in Table 1 was performed according to the 287 maximum CD spectrum reading for each sonication; thus, if the sonication is classified as stable, it 288 is assumed that no inertial cavitation has taken place. From Table 1 , it can be seen that the 289 occurrence of inertial cavitation decreases over time, corresponding to the order of sonication, 290 whilst stable cavitation occurs instead. Our results show that the recorded CD = 0.22 ± 0.06mV and 291 higher correspond to the occurrence of inertial cavitation, whereas CD = 0.15 ± 0.02 mV and lower 292 correlate with stable cavitation. 293 Figure 6 presents the dependence of the drug uptake, membrane permeability and CD on the time 294 passing after the first sonication. As previously mentioned, the treatment groups without MB were 295 sonicated last. It can be seen that sonications without the MBs produce consistent results both for 296 the intracellular drug uptake and membrane permeability, with up to 20% variation from the 297 14 average value: these results are not time dependent. On the other hand, sonications performed on 298 the wells with MBs manifest a bigger span of results and are time-dependent. 299
The dependence of immediate viability and cell recovery studies on the order of the sonications is 300 presented in Figure 7A and B, respectively. The trend-lines shown in Figures 6 and 7 are the linear 301 fitting representations of the dependence of the groups containing MBs on the order of sonication. 302
Discussion 303
This study was designed to define the individual contributions of stable and inertial cavitation to 304 intracellular uptake of a chemotherapic agent within cancer cells. The initial step was the 305 characterisation of the experimental arrangements including 96-well plates sonicated with a 306 clinically approved system. This has confirmed that the use of the standard cell culture environment 307 does not compromise the properties of the ultrasound propagation. Moreover, the acoustic energy 308 levels that were used do not cause significant thermal effects, allowing differentiation between 309 hyperthermia and cavitation. 310
Our Dox uptake results indicate a threshold between drug uptake and cavitation activity with and 311 without MBs. While there was no effect on either the uptake or the membrane permeability in the 312 absence of MBs, the intracellular drug uptake was, on average, increased by a factor of 2.14 ± 0.46 313 relative to the control group in the presence of MBs. 314
Membrane integrity tests were conducted to gain better understanding of the mechanism of uptake 315 enhancement by MBs in acoustic environment. The membrane integrity assay quantified the level 316 of LDH present in the media due to leaking cell membranes. Accordingly, it was possible to 317 evaluate the membrane permeability achieved by sonication. In this study we utilised a simple 318 fluorescence-based measurement technique to validate the mechanism of drug uptake into the cells. 319
The close correlation between the increases in cellular uptake and the membrane permeability (i.e. 320 3.2 and 3.5 fold, respectively) indicate that membrane permeability studies involving quantification 321 of LDH levels can be used as a tool to establish the levels of membrane permeability caused by the 322 application of ultrasound. 323
15
The average decrease in viability of cells immediately after sonication in the wells containing MBs 324 was recorded as 31% ± 8% relative to the control group. Taken together with the 24 h recovery 325 studies, where the average decrease in the same group was 19% ± 5%, this indicates that some of 326 the cell damage caused by sonication was reversible and did not lead directly to cell death. 327
Therefore we conclude that there is an acoustic intensity window inside which the permeability of 328 the cell membranes increases due to the presence of ultrasound-driven MBs which allows greater 329 intracellular drug uptake, while permeabilisation is not permanent as it does not cause excessively 330 high levels of cell death. 331
The drug uptake dependence on cell loss along with the cell viability studies indicated that greater 332 cell loss is caused by the increased uptake of toxic drugs into the cells, rather than for any other 333 reason. The average results of the cell culture studies are in agreement with previously described 334 work by other authors using different experimental configurations (Pitt et al. 2004) . 335
The dependence of drug uptake on CD indicates that greater uptake is achieved for smaller values 336 of CD, i.e. 0.12 mV < CD < 0.19 mV, suggesting that stable, non-linear cavitation with a peak at ½ 337 the transmitting frequency is responsible for greater uptake and membrane permeability. Indeed, 338 sorting the results according to the order of the sonicated wells, we have found that inertial 339 cavitation occurred mainly within the first four sonicated wells, whereas stable cavitation was 340 detected mainly in the last three sonicated wells that contained MBs. From the representation of the 341 results as a function of time starting at the first sonication, there is a trend of increased drug uptake 342 and reduced CD. This suggests that the increased drug uptake into the cell monolayers in our 343 experiments was caused by stable, rather than inertial, cavitation. The dependence of the uptake on 344 cell loss shows that stable cavitation also caused a greater cell loss. This is also evident in the 345 immediate viability studies where there is a reduction in viability as a function of time similar to the 346 CD. Nonetheless, this trend is decreased in the 24 h recovery studies as shown by the fact that the 347 slope of the linear trend in the 24 h viability is half that generated from immediate viability studies. 348 16 We have calculated that the initial MB concentration was enough to cover the surface of the cells in 349 a single monolayer, yet not high enough to attenuate the ultrasound beam. Therefore, we 350 hypothesize that the initial inertial cavitation in our experiments, during the first three sonications 
Conclusions 361
In this study, a clinically approved MRgFUS system was used for cell studies in vitro. Adaptation 362 of a clinical system in this way carries the potential for use of a single system from in vitro studies 363 through the pre-clinical stage to clinical trials. Moreover, a well-defined experimental setup that can 364 be used in a clinical environment promotes a reproducible baseline of in vitro and in vivo results, 365 which can promote related research, e.g. in conjugation with novel drug carriers (Wang and 366 Thanoua 2010), in multiple centres. The ability offered by this system to quantify cavitation dose 367 has the potential to explain previously obscure results. The method used for cavitation detection in 368 this study has advantages of robustness and simplicity. More precise cavitation detection methods 369 have been suggested by Gyongy and Coussios, 2010. The use of the passive cavitation detection 370 method they describe, along with the method described in our work, will allow better localization of 371 cavitation and correlation between the sub-harmonics and harmonics and the intracellular drug 372 uptake. 373
The absolute values of the drug uptake results presented here are in line with previously reported 374 work by other authors using different experimental configurations. Moreover, the spectral recording 375 that has been performed has allowed us to determine that the highest drug uptake was achieved in 376 the presence of stable, non-linear cavitation. According to our findings, there is higher uptake at 377 lower CD values. This is contradictory to the common assumption that UmTDD is governed by 378 inertial cavitation (Somaglino et al. 2011; Razavi et al. 2014 ). Here we have provided evidence that 379 stable cavitation with a lower CD, in the presence of MB, produces a greater impact on the 380 intracellular uptake. This should be taken into account in future cavitation related TDD studies. 381
Moreover, the hypothesis driven from our studies with Sonovue MB suggests that the time for 382 ultrasound application to the MB is crucial and should be carefully controlled and reported in the 383 literature. 384
